FibroGen, Inc. (FGEN)

1.0400 +0.0200 (+1.96%) 收市：04:00PM EDT

FibroGen, Inc.

409 Illinois Street
San Francisco, CA 94158
United States
415 978 1200
https://www.fibrogen.com

版塊: Healthcare
行業: Biotechnology
全職員工: 486

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Thane Wettig	CEO & Director	941.79k	無	1965
Mr. Juan Graham	Senior VP & CFO	892.49k	無	1977
Ms. Christine L. Chung	Senior Vice President of China Operations	915.36k	無	1968
Dr. Barry A. Berkowitz Ph.D.	Founder	無	無	無
Dr. John J. Hunter Ph.D.	Chief Scientific Officer	無	無	1963
David DeLucia	Vice President of Corporate FP&A and Investor Relations	無	無	無
Mr. Michael D. Lowenstein J.D., Ph.D.	Chief Legal Officer	無	無	無
Ms. Tricia Stewart	Chief People Officer	無	無	無
Mr. Kirk A. Christoffersen MBA	Chief Business Officer	無	無	1969
Dr. Rahul Rajan Kaushik Ph.D.	Senior Vice President of Pharmaceutical Development, Technical Operations & Manufacturing	無	無	無

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

公司管治

截至 2024年4月1日 止，FibroGen, Inc. 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中：9；董事會：2；股東權利：8；現金賠償：9。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。